Audit 40245

FY End
2022-08-31
Total Expended
$836,352
Findings
0
Programs
1
Organization: Bay Area Tumor Institute (CA)
Year: 2022 Accepted: 2022-12-19
Auditor: Jhs CPAS LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.399 Cancer Control $836,352 Yes 0

Contacts

Name Title Type
KFD4ZKUJQKJ7 Barry B. Siegel Auditee
5104658571 Michael R. Huhn Auditor
No contacts on file

Notes to SEFA

Accounting Policies: NOTE 1BASIS OF PRESENTATIONThe accompanying Schedule of Expenditures of Federal Awards (the Schedule) has been prepared on the accrual basis of accounting, and the schedule includes the federal grant activity of Bay Area Tumor Institute under programs of the federal government for the year ended August 31, 2022. The information in this schedule is presented in accordance with the requirements of the Office of Management and Budget (OMB) Uniform Guidance. Because the Schedule presents only a selected portion of the operations of Bay Area Tumor Institute, it is not intended to and does not present the financial position, change in net assets or cash flows of Bay Area Tumor Institute.NOTE 2SUMMARY OF SIGNIFICANT ACCOUNTING POLICIESExpenditures reported on the Schedule are recognized following the cost principles contained in 2 CFR Part 200, Cost Principles for Non-Profit Organizations, wherein certain types of expenditures are not allowable or are limited as to reimbursement.NOTE 3SUBRECIPIENTSCertain funds are passed through to a subrecipient organization, The regents of the University of California on behalf of UCSF Benioff Children's Hospital Oakland, by the Institute. For the year ended August 31, 2022, expenditures incurred by the subrecipient and reimbursed by the Institute are $208,935 which is included in the Schedule under the federal CFDA number 93.399. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.